BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 14, 2026; 32(38): 120967
Published online Oct 14, 2026. doi: 10.3748/wjg.120967
Table 1 Timeline of clinical events
Year
Clinical events
ChildhoodSplenectomy
May 2024Ischemic stroke. US: Focal liver lesion
June 2024Contrast-enhanced abdominal MSCT: Focal lesions of unknown etiology
July 2024MRI: Focal lesion suspicious of HCC
August 2024Referring to the Department of Gastroenterology
September 2024Percutaneous biopsy of non-lesional liver tissue: Healthy liver parenchyma; Normal tumor marker values
October 2024Radiological multidisciplinary meeting: Bleeding risk from biopsy; Surgery chosen as diagnostic and therapeutic modality
November 2024Surgical resection of the focal liver lesion. Histopathological analysis: Intrahepatic splenosis
November 2024 to April 2025Regular follow-ups. Further evaluation if clinically indicated
Table 2 Summary of epidemiological and clinical characteristics of reported cases of intrahepatic splenosis[4,9-85]
Epidemiological and clinical characteristics
Cases, n
%
Male sex16481
Age > 40 years16076
Splenectomy
Overall7796
Due to trauma26586
Cirrhosis79
Table 3 Diagnostic methods for intrahepatic splenosis according to initial differential diagnosis and presence of extrahepatic lesions[9,10,12-15,17-54,56-63,65-70,72-74,76,77,79-85]
Extrahepatic lesions
Primary differential diagnosis
Diagnosis
Count
NoHCCBiopsy8
Surgery22
Scintigraphy3
Other malignancyBiopsy2
Surgery6
Scintigraphy1
Benign (non-HS)Biopsy3
Surgery9
Scintigraphy2
HSBiopsy3
Scintigraphy2
YesHCCSurgery2
Scintigraphy1
Other malignancySurgery2
Scintigraphy1
Benign (non-HS)Scintigraphy2
HSBiopsy1
Scintigraphy3


Write to the Help Desk